Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
667.00    0.00 (0.00%)
Bid:
0.00
Ask:
825.00
Spread: 157.00 (23.503%)
Market Cap: £581.12m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Board Appointments

28 Jul 2008 12:54

RNS Number : 0203A
Victrex PLC
28 July 2008
 



 28 July 2008

Victrex plc

BOARD APPOINTMENTS

The Board of Victrex plc is pleased to announce the appointments of Patrick De Smedt and Lawrence Pentz as non-executive directors of the Company with effect from 28 July 2008

Patrick De Smedt, aged 53was, until recently, Chairman of Microsoft Europe, Middle East & Africa. He joined Microsoft in 1983 as one of its pioneers in Europe. When Patrick left Microsoft at the end of 2006, the EMEA region generated revenues of $12 billion with a headcount of 12,000 employees. Patrick currently serves on the boards of a number of European companies

Lawrence Pentz, aged 53, has been a main board director of Johnson Matthey plc since 2003. He is currently Executive Director, responsible for their Emission Control Technologies businessPrior to this Lawrence was Executive Director, Process Catalyst and Technologies.

Anita FrewChairman Elect of Victrex plc, said:

"I am delighted to welcome Patrick and Lawrence to the Board. They have each demonstrated outstanding success in their businesses .Their breadth of international and industrial experience and their knowledge of market and geographical development will contribute significantly to our Board."

No further information in relation to Mr De Smedt or Mr Pentz is required to be disclosed pursuant to Listing Rule 9.6.13R.

As at 28 July 2008neither Mr De Smedt nor Mr Pentz had any beneficial interests in the share capital of the Company.

Enquiries

Victrex plc

Anita FrewChairman Elect 01253 897700

David HummelChief Executive 01253 897700

 

Hogarth Partnership Limited

Nick Denton / Barnaby Fry 0207 357 9477

Victrex plc is an innovative, world leader in high performance materials through the manufacture of VICTREX® PEEK™ polymer, a high performance, easy to process thermoplastic.

VICTREX PEEK has a unique combination of chemical, wear, electrical, hydrolysis and temperature resistance, as well as excellent dimensional, mechanical and chemical stability combined with inherent purity and low flammability

End users specify VICTREX PEEK to reduce systems costs, improve part performance, exploit greater design freedom and create a differentiated application. VICTREX PEEK is used across a broad range of applications in diverse markets including transport, industrial, electronics and medical. Invibio®, Victrex's biomaterials business, provides specialised solutions for medical device manufacturers.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAFXPASDPEFE
Date   Source Headline
17th May 202310:55 amRNSDirector/PDMR Shareholding
16th May 202310:03 amRNSDirector/PDMR Shareholding
12th May 202310:37 amRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
10th May 20231:34 pmRNSDirector/PDMR Shareholding
9th May 20237:00 amRNSVictrex plc - Interim Results 2023
28th Apr 20239:33 amRNSTotal Voting Rights
18th Apr 20232:00 pmRNSHolding(s) in Company
18th Apr 202310:50 amRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSDirectorate Change
31st Mar 202310:52 amRNSTotal Voting Rights
20th Mar 20233:07 pmRNSHolding(s) in Company
20th Mar 202310:15 amRNSDirector/PDMR Shareholding
13th Mar 202310:14 amRNSAdditional Listing
28th Feb 20239:35 amRNSTotal Voting Rights
17th Feb 202310:06 amRNSDirector/PDMR Shareholding
14th Feb 202312:20 pmRNSDirector/PDMR Shareholding
10th Feb 20232:12 pmRNSDirector/PDMR Shareholding
10th Feb 202312:29 pmRNSResult of AGM
10th Feb 20237:00 amRNSAGM & Q1 Interim Management Statement
31st Jan 202310:43 amRNSTotal Voting Rights
17th Jan 20232:12 pmRNSDirector/PDMR Shareholding
12th Jan 20232:28 pmRNSCorrection - AGM Resolution Proposal
6th Jan 20232:58 pmRNSAnnual Report and Accounts
30th Dec 20229:00 amRNSTotal Voting Rights
22nd Dec 202211:30 amRNSDirector/PDMR Shareholding
19th Dec 202212:04 pmRNSDirector/PDMR Shareholding
19th Dec 202210:56 amRNSDirector/PDMR Shareholding
13th Dec 202211:16 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSVictrex plc – Preliminary Results 2022
1st Dec 202211:49 amRNSBlock listing Interim Review
30th Nov 20229:27 amRNSTotal Voting Rights
29th Nov 20224:05 pmRNSHolding(s) in Company
17th Nov 20222:50 pmRNSDirector/PDMR Shareholding
17th Nov 20221:35 pmRNSAdditional Listing
31st Oct 202212:55 pmRNSTotal Voting Rights
18th Oct 202212:26 pmRNSDirector/PDMR Shareholding
30th Sep 202211:03 amRNSTotal Voting Rights
28th Sep 20229:44 amRNSHolding(s) in Company
20th Sep 20224:05 pmRNSDirector/PDMR Shareholding
31st Aug 20229:00 amRNSTotal Voting Rights
17th Aug 20222:31 pmRNSDirector/PDMR Shareholding
29th Jul 202210:01 amRNSTotal Voting Rights
19th Jul 20222:41 pmRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSVictrex Q3 Interim Management Statement
30th Jun 202210:28 amRNSTotal Voting Rights
21st Jun 202212:41 pmRNSDirector/PDMR Shareholding
7th Jun 202211:45 amRNSBlock listing Interim Review
31st May 20229:59 amRNSTotal Voting Rights
27th May 20229:40 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.